Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion

Microbes and Infection

Volumn 6, Issue 5, 2004, Pages 414-420

  Ling, Hong ^a,b   Xiao, Peng ^a,b   Usami, Osamu ^a   Hattori, Toshio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Binding site; BS; Envelope; Fusion; HIV; HIV 1; Human immunodeficiency virus; Mean fluorescence intensity; MFI; PBS; Phosphate buffered saline; Thrombin

Indexed keywords

CATHEPSIN G; CHYMOTRYPSIN; EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY; THROMBIN; TRYPSIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CELL CULTURE; CELL FUSION; COCULTURE; CONCENTRATION RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CATHEPSINS; CELL FUSION; CELL LINE; CHYMOTRYPSIN; EPITOPES; FLOW CYTOMETRY; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; PEPTIDE FRAGMENTS; SERINE ENDOPEPTIDASES; THROMBIN; TRYPSIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1942517392     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.01.010     Document Type: Article

References (32)

1. Clements G.J., Price-Jones M.J., Stephens P.E., Sutton C., Schulz T.F., Clapham P.R., McKeating J.A., McClure M.O., Thomson S., Marsh M., Kay J., Weiss R.A., Moore J.P. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses. 7:1991;3-16.
2. Papandreou M.J., Fenouillet E. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain. Virology. 241:1998;163-167.
3. Schulz T.F., Reeves J.D., Hoad J.G., Tailor C., Stephens P., Clements G., Ortlepp S., Page K.A., Moore J.P., Weiss R.A. Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage. AIDS Res. Hum. Retroviruses. 9:1993;159-166.
4. Niwa Y., Yano M., Futaki S., Okumura Y., Kido H. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120. Eur. J. Biochem. 237:1996;64-70.
5. Avril L.E., Martino-Ferrer D.M., Brillard-Bourdet M., Gauthier F. Inhibition of U937 membrane-associated cathepsin G by gp120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1. FEBS Lett. 367:1995;251-256.
6. Hill C.M., Deng H., Unutmaz D., Kewalramani V.N., Bastiani L., Gorny M.K., Zolla-Pazner S., Littman D.R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:1997;6296-6304.
7. Werner A., Levy J.A. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. J. Virol. 67:1993;2566-2574.
8. El Messaoudi K., Thiry L.F., Liesnard C., Van Tieghem N., Bollen A., Moguilevsky N. A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J. Virol. 74:2000;1004-1007.
9. Handley M.A., Steigbigel R.T., Morrison S.A. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J. Virol. 70:1996;4451-4456.
10. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
11. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
12. Ling H., Zhang X.Y., Usami O., Hattori T. Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides. Biochem. Biophys. Res. Commun. 297:2002;625-631.
13. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
14. Gorny M.K., Xu J.Y., Karwowska S., Buchbinder A., Zolla-Pazner S. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150:1993;635-643.
15. Chesebro B., Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. Virol. 62:1988;3779-3788.
16. Laman J.D., Schellekens M.M., Abacioglu Y.H., Lewis G.K., Tersmette M., Fouchier R.A., Langedijk J.P., Claassen E., Boersma W.J. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain. J. Virol. 66:1992;1823-1831.
17. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:1998;4694-4703.
18. Posner M.R., Hideshima T., Cannon T., Mukherjee M., Mayer K.H., Byrn R.A. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 146:1991;4325-4332.
19. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:1993;6642-6647.
20. Xu J.Y., Gorny M.K., Palker T., Karwowska S., Zolla-Pazner S. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J. Virol. 65:1991;4832-4838.
21. Gorny M.K., Gianakakos V., Sharpe S., Zolla-Pazner S. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;1624-1628.
22. Endres M.J., Clapham P.R., Marsh M., Ahuja M., Turner J.D., McKnight A., Thomas J.F., Stoebenau-Haggarty B., Choe S.S., Vance P.J., Wells T.N., Power C.A., Sutterwala S.S., Doms R.W., Landau N.R., Hoxie J.A. CD4-independent infection by HIV-2 is mediated by fusion/CXCR4. Cell. 87:1996;745-756.
23. Eckert M.D., Malashkevich V.N., Hong L.H., Carr P.A., Kim P.S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp 41 coiled-coil pocket. Cell. 99:1999;103-115.
24. Stephens P.E., Clements G., Yarranton G.T., Moore J. A chink in HIV's armour? Nature. 343:1990;219.
25. Nyambi P.N., Mbah H.A., Burda S., Williams C., Gorny M.K., Nadas A., Zolla-Pazner S. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J. Virol. 74:2000;7096-7107.
26. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
27. Stryer L. Stryer L. Biochemistry. 1995;56 W.H. Freeman and Company, New York.
28. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.
29. Hoffman M., Church F.C. Response of blood leukocytes to thrombin receptor peptides. J. Leuko. Biol. 54:1993;145-151.
30. Mari B., Guerin S., Far D.F., Breitmayer J.P., Belhacene N., Peyron J.F., Rossi B., Auberger P. Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J. 10:1996;309-316.
31. Hirano F., Kobayashi A., Hirano Y., Nomura Y., Fukawa E., Makino I. Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts. Ann. Rheum. Dis. 61:2002;834-837.
32. Szaba F.M., Smiley S.T. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood. 99:2002;1053-1059.